Literature DB >> 8749215

Follow-up after colorectal cancer: current practice in The Netherlands.

D J Bruinvels1, A M Stiggelbout, M P Klaassen, J Kievit, J Dik, F Habbema, C J Van de Velde.   

Abstract

OBJECTIVE: To assess the current practice of follow-up after operations for colorectal cancer in The Netherlands in comparison with other countries.
DESIGN: Postal survey.
SETTING: All surgical departments in The Netherlands. MAIN OUTCOME MEASURES: Attitudes of surgeons towards detection and treatment of recurrences after colorectal cancer.
RESULTS: Of the 139 questionnaires sent out, 136 (98%) were returned. History taking, physical examination, and colonoscopy for local recurrence and metachronous tumours were used by 90% of the hospitals. Attitudes towards screening for hepatic and pulmonary metastases and regional recurrence varied considerably between hospitals. Similar findings were found in seven surveys from other countries.
CONCLUSION: There is no consensus among surgeons regarding the follow-up of patients with colorectal cancer. Randomised controlled trials comparing different follow-up strategies and cost-effectiveness analyses are needed to identify groups of patients that will benefit most from follow-up. Identification of these patients may lead to more agreement between surgeons.

Entities:  

Mesh:

Year:  1995        PMID: 8749215

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  3 in total

Review 1.  Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials.

Authors:  Andrew G Renehan; Matthias Egger; Mark P Saunders; Sarah T O'Dwyer
Journal:  BMJ       Date:  2002-04-06

2.  Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer.

Authors:  Andrew G Renehan; Sarah T O'Dwyer; David K Whynes
Journal:  BMJ       Date:  2004-01-10

3.  Should the surgeon or the general practitioner (GP) follow up patients after surgery for colon cancer? A randomized controlled trial protocol focusing on quality of life, cost-effectiveness and serious clinical events.

Authors:  Knut M Augestad; Barthold Vonen; Ranveig Aspevik; Torunn Nestvold; Unni Ringberg; Roar Johnsen; Jan Norum; Rolv-Ole Lindsetmo
Journal:  BMC Health Serv Res       Date:  2008-06-25       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.